Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Lupus nephritis"" wg kryterium: Temat


Tytuł :
Lupus nephritis: clinical presentations and outcomes in the 21st century.
Autorzy :
Gasparotto M; Rheumatology Unit, Department of Medicine, University of Padua.
Gatto M; Rheumatology Unit, Department of Medicine, University of Padua.
Binda V; Nephrology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Doria A; Rheumatology Unit, Department of Medicine, University of Padua.
Moroni G; Nephrology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Pokaż więcej
Źródło :
Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2020 Dec 05; Vol. 59 (Suppl5), pp. v39-v51.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Lupus Nephritis/*diagnosis
Disease Progression ; Humans ; Lupus Nephritis/classification ; Lupus Nephritis/pathology ; Lupus Nephritis/therapy ; Prognosis ; Recurrence ; Remission Induction ; Risk Factors
Czasopismo naukowe
Tytuł :
Advances in ANCA-associated vasculitis and lupus nephritis.
Autorzy :
Ayoub I; Department of Medicine, Division of Nephrology, The Ohio State University Wexner Medical Center, Columbus, OH, USA. .
Nachman PH; Department of Medicine, Division of Nephrology and Hypertension, University of Minnesota, Minneapolis, MN, USA.
Pokaż więcej
Źródło :
Nature reviews. Nephrology [Nat Rev Nephrol] 2021 Feb; Vol. 17 (2), pp. 89-90.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/*therapy
Lupus Nephritis/*therapy
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/diagnosis ; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/etiology ; Humans ; Lupus Nephritis/diagnosis ; Lupus Nephritis/etiology
Czasopismo naukowe
Tytuł :
Hydralazine induced lupus nephritis after prolonged exposure.
Autorzy :
Sarwal A; Department of Internal Medicine, Lincoln Medical Center, NY, USA. Electronic address: .
Gnanasekaran I; Department of Internal Medicine, Lincoln Medical Center, NY, USA.
Pokaż więcej
Źródło :
The American journal of the medical sciences [Am J Med Sci] 2021 Jan; Vol. 361 (1), pp. 130-131. Date of Electronic Publication: 2020 Jul 07.
Typ publikacji :
Case Reports; Letter
MeSH Terms :
Antihypertensive Agents/*adverse effects
Hydralazine/*adverse effects
Lupus Nephritis/*diagnosis
Vasodilator Agents/*adverse effects
Aged ; Female ; Humans ; Lupus Nephritis/chemically induced ; Lupus Nephritis/drug therapy ; New York
Raport
Tytuł :
Lupus nephritis-related issues during COVID-19 pandemic quarantine.
Autorzy :
Pedrosa T; Rheumatology Division, Faculdade Medicina, Hospital das Clinicas HCFMUSP, Universidade de Sao Paulo, Sao Paulo, Brazil.
Kupa LVK; Rheumatology Division, Faculdade Medicina, Hospital das Clinicas HCFMUSP, Universidade de Sao Paulo, Sao Paulo, Brazil.
Aikawa NE; Rheumatology Division, Faculdade Medicina, Hospital das Clinicas HCFMUSP, Universidade de Sao Paulo, Sao Paulo, Brazil.; Pediatric Rheumatology Unit, Pediatric Department, Faculdade Medicina, Hospital das Clinicas HCFMUSP, Universidade de Sao Paulo, Sao Paulo, Brazil lead*The authors contributed equally to this paper.
Pasoto SG; Rheumatology Division, Faculdade Medicina, Hospital das Clinicas HCFMUSP, Universidade de Sao Paulo, Sao Paulo, Brazil.
Bonfá E; Rheumatology Division, Faculdade Medicina, Hospital das Clinicas HCFMUSP, Universidade de Sao Paulo, Sao Paulo, Brazil.
Silva CA; Rheumatology Division, Faculdade Medicina, Hospital das Clinicas HCFMUSP, Universidade de Sao Paulo, Sao Paulo, Brazil.; Pediatric Rheumatology Unit, Pediatric Department, Faculdade Medicina, Hospital das Clinicas HCFMUSP, Universidade de Sao Paulo, Sao Paulo, Brazil lead*The authors contributed equally to this paper.
Pokaż więcej
Źródło :
Lupus [Lupus] 2020 Dec; Vol. 29 (14), pp. 1978-1980. Date of Electronic Publication: 2020 Sep 02.
Typ publikacji :
Letter; Research Support, Non-U.S. Gov't
MeSH Terms :
COVID-19*/epidemiology
COVID-19*/prevention & control
COVID-19*/psychology
Fear*
Lupus Nephritis*/epidemiology
Lupus Nephritis*/physiopathology
Lupus Nephritis*/therapy
Quarantine*/methods
Quarantine*/psychology
Telecommunications*
Antirheumatic Agents/*therapeutic use
Adult ; Brazil/epidemiology ; Female ; Humans ; Male ; Psychology ; SARS-CoV-2 ; Socioeconomic Factors ; Surveys and Questionnaires ; Tertiary Healthcare/methods
Raport
Tytuł :
Renal deposits of complement factors as predictors of end-stage renal disease and death in patients with lupus nephritis.
Autorzy :
Koopman JJE; Division of Renal Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Department of Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands.
Rennke HG; Renal Pathology Service, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Leatherwood C; Department of Rheumatology, Richmond Medical Center, Kaiser Permanente Medical Group, Richmond, CA, USA.
Speyer CB; Division of Rheumatology, Immunology, and Allergy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
D'Silva K; Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
McMahon GM; Division of Renal Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Waikar SS; Division of Renal Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Costenbader KH; Division of Rheumatology, Immunology, and Allergy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Pokaż więcej
Źródło :
Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2020 Dec 01; Vol. 59 (12), pp. 3751-3758.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Complement C1q/*metabolism
Complement C3/*metabolism
Kidney/*metabolism
Kidney Failure, Chronic/*metabolism
Lupus Nephritis/*metabolism
Adult ; Boston/epidemiology ; Female ; Humans ; Kidney Failure, Chronic/immunology ; Lupus Nephritis/complications ; Lupus Nephritis/mortality ; Male ; Middle Aged ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Are new treatments for lupus nephritis on the horizon?
Autorzy :
Ginzler EM; Department of Medicine, State University of New York Downstate Health Sciences University, Brooklyn, New York, USA. Electronic address: .
Pokaż więcej
Źródło :
Kidney international [Kidney Int] 2021 Feb; Vol. 99 (2), pp. 298-300.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Lupus Nephritis*/drug therapy
Antibodies, Monoclonal, Humanized ; Humans
Czasopismo naukowe
Tytuł :
Belimumab in Lupus Nephritis. Reply.
Autorzy :
Furie R; Northwell Health, Great Neck, NY .
Rovin BH; Ohio State University, Columbus, OH.
Roth DA; GlaxoSmithKline, Collegeville, PA.
Pokaż więcej
Źródło :
The New England journal of medicine [N Engl J Med] 2021 Jan 14; Vol. 384 (2), pp. 188.
Typ publikacji :
Letter; Comment
MeSH Terms :
Lupus Nephritis*/drug therapy
Antibodies, Monoclonal, Humanized/therapeutic use ; Humans ; Immunosuppressive Agents/therapeutic use
Opinia redakcyjna
Tytuł :
Belimumab in Lupus Nephritis.
Autorzy :
Schönermarck U; Ludwig-Maximilians-Universität München, Munich, Germany .
Kemmner S; Ludwig-Maximilians-Universität München, Munich, Germany .
Fischereder M; Ludwig-Maximilians-Universität München, Munich, Germany .
Pokaż więcej
Źródło :
The New England journal of medicine [N Engl J Med] 2021 Jan 14; Vol. 384 (2), pp. 187-188.
Typ publikacji :
Letter; Comment
MeSH Terms :
Lupus Nephritis*/drug therapy
Antibodies, Monoclonal, Humanized/therapeutic use ; Humans ; Immunosuppressive Agents/therapeutic use
Opinia redakcyjna
Tytuł :
Belimumab in Lupus Nephritis.
Autorzy :
Rojas-Rivera J; Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain .
Ortiz A; Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain .
Carriazo S; Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain .
Pokaż więcej
Źródło :
The New England journal of medicine [N Engl J Med] 2021 Jan 14; Vol. 384 (2), pp. 187.
Typ publikacji :
Letter; Comment
MeSH Terms :
Lupus Nephritis*/drug therapy
Antibodies, Monoclonal, Humanized/therapeutic use ; Humans ; Immunosuppressive Agents/therapeutic use
Opinia redakcyjna
Tytuł :
[Advances in induction therapy drugs of lupus nephritis for children].
Autorzy :
Yuan C; Department of Nephrology and Rheumatology,Shanghai Children's Hospital, Shanghai Jiao Tong University, Shanghai 200062, China.
Huang WY; Department of Nephrology and Rheumatology,Shanghai Children's Hospital, Shanghai Jiao Tong University, Shanghai 200062, China.
Pokaż więcej
Źródło :
Zhonghua er ke za zhi = Chinese journal of pediatrics [Zhonghua Er Ke Za Zhi] 2021 Jan 02; Vol. 59 (1), pp. 71-74.
Typ publikacji :
Journal Article
MeSH Terms :
Lupus Nephritis*/drug therapy
Pharmaceutical Preparations*
Child ; Cyclophosphamide/therapeutic use ; Humans ; Immunosuppressive Agents/therapeutic use ; Induction Chemotherapy ; Mycophenolic Acid/therapeutic use ; Remission Induction
Czasopismo naukowe
Tytuł :
Increased plasma levels of Gas6 and its soluble tyrosine kinase receptors Mer and Axl are associated with immunological activity and severity of lupus nephritis.
Autorzy :
Bellan M; Department of Translational Medicine, Università del Piemonte Orientale, Novara; Internal Medicine Division, Maggiore della Carità Hospital, Novara; IRCAD, Interdisciplinary Research Center of Autoimmune Diseases, Novara, Italy. .
Quaglia M; Department of Translational Medicine, Università del Piemonte Orientale, Novara; IRCAD, Interdisciplinary Research Center of Autoimmune Diseases, Novara; and Division of Nephrology and Renal Transplantation, Maggiore della Carità Hospital, Novara, Italy.
Nerviani A; Centre for Experimental Medicine and Rheumatology, Barts and The London School of Medicine and Dentistry, William Harvey Research Institute, Queen Mary University of London, UK.
Mauro D; Centre for Experimental Medicine and Rheumatology, Barts and The London School of Medicine and Dentistry, William Harvey Research Institute, Queen Mary University of London, UK.
Lewis M; Centre for Experimental Medicine and Rheumatology, Barts and The London School of Medicine and Dentistry, William Harvey Research Institute, Queen Mary University of London, UK.
Goegan F; Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
Gibbin A; Department of Translational Medicine, Università del Piemonte Orientale, Novara; and Internal Medicine Division, Maggiore della Carità Hospital, Novara, Italy.
Pagani S; Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
Salmi L; Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
Molinari L; Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
Castello LM; Department of Translational Medicine, Università del Piemonte Orientale, Novara; and Emergency Medicine Department, Maggiore della Carità Hospital, Novara, Italy.
Avanzi GC; Department of Translational Medicine, Università del Piemonte Orientale, Novara; and Emergency Medicine Department, Maggiore della Carità Hospital, Novara, Italy.
Cantaluppi V; Department of Translational Medicine, Università del Piemonte Orientale, Novara; IRCAD, Interdisciplinary Research Center of Autoimmune Diseases, Novara; and Division of Nephrology and Renal Transplantation, Maggiore della Carità Hospital, Novara, Italy.
Pirisi M; Department of Translational Medicine, Università del Piemonte Orientale, Novara; and Internal Medicine Division, Maggiore della Carità Hospital, Novara, Italy.
Sainaghi PP; Department of Translational Medicine, Università del Piemonte Orientale, Novara; Internal Medicine Division, Maggiore della Carità Hospital, Novara; IRCAD, Interdisciplinary Research Center of Autoimmune Diseases, Novara, Italy.
Pitzalis C; Centre for Experimental Medicine and Rheumatology, Barts and The London School of Medicine and Dentistry, William Harvey Research Institute, Queen Mary University of London, UK.
Pokaż więcej
Źródło :
Clinical and experimental rheumatology [Clin Exp Rheumatol] 2021 Jan-Feb; Vol. 39 (1), pp. 132-138. Date of Electronic Publication: 2020 Jun 04.
Typ publikacji :
Journal Article
MeSH Terms :
Lupus Nephritis*/diagnosis
Receptor Protein-Tyrosine Kinases*
Biomarkers ; Humans ; Intercellular Signaling Peptides and Proteins ; Plasma ; Proto-Oncogene Proteins
Czasopismo naukowe
Tytuł :
[Clinicopathological features of children with lupus nephritis with positive antineutrophil cytoplasmic antibody].
Autorzy :
Wen SJ; Children Kidney Disease Center, First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China.
Chen LZ; Children Kidney Disease Center, First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China.
Cheng C; Children Kidney Disease Center, First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China.
Lin ZL; Children Kidney Disease Center, First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China.
Mo Y; Children Kidney Disease Center, First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China.
Jiang XY; Children Kidney Disease Center, First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China.
Pokaż więcej
Źródło :
Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics [Zhongguo Dang Dai Er Ke Za Zhi] 2021 Jan; Vol. 23 (1), pp. 55-60.
Typ publikacji :
Journal Article
MeSH Terms :
Antibodies, Antineutrophil Cytoplasmic*
Lupus Nephritis*
Child ; Creatinine ; Humans ; Kidney ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Performance of the systemic lupus erythematosus disease activity score (SLE-DAS) in a Latin American population.
Autorzy :
Rodríguez-González MG; Departamento de Reumatología, Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, Mexico.
Valero-Gaona GA; Departamento de Reumatología, Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, Mexico.
Vargas-Aguirre T; Departamento de Reumatología, Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, Mexico.
Amezcua Guerra LM; Departamento de Inmunología, Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, Mexico .
Pokaż więcej
Źródło :
Annals of the rheumatic diseases [Ann Rheum Dis] 2020 Dec; Vol. 79 (12), pp. e158. Date of Electronic Publication: 2019 Jul 29.
Typ publikacji :
Letter; Comment
MeSH Terms :
Lupus Erythematosus, Systemic*/epidemiology
Lupus Nephritis*
Hispanic Americans ; Humans ; Latin America/epidemiology ; Longitudinal Studies
Opinia redakcyjna
Tytuł :
The predictive value of crescents in the disease progression of lupus nephritis based on the 2018 International Society of Nephrology/Renal Pathology Society Revision System: a large cohort study from China.
Autorzy :
Tao J; Renal Division, Department of Medicine, Peking University First Hospital, Beijing, People's Republic of China.; Institute of Nephrology, Peking University, Beijing, People's Republic of China.; Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, People's Republic of China.; Key Laboratory of CKD Prevention and Treatment, Ministry of Education of China, Beijing, People's Republic of China.
Wang H; Laboratory of Electron Microscopy, Peking University First Hospital, Beijing, People's Republic of China.
Wang SX; Laboratory of Electron Microscopy, Peking University First Hospital, Beijing, People's Republic of China.
Yu F; Renal Division, Department of Medicine, Peking University First Hospital, Beijing, People's Republic of China.; Department of Nephrology, Peking University International Hospital, Beijing, People's Republic of China.
Zhao MH; Renal Division, Department of Medicine, Peking University First Hospital, Beijing, People's Republic of China.; Peking-Tsinghua Center for Life Sciences, Beijing, People's Republic of China.
Pokaż więcej
Źródło :
Renal failure [Ren Fail] 2020 Nov; Vol. 42 (1), pp. 166-172.
Typ publikacji :
Journal Article
MeSH Terms :
Kidney Glomerulus/*pathology
Lupus Nephritis/*diagnosis
Lupus Nephritis/*pathology
Nephrology/*methods
Adult ; Biopsy ; China/epidemiology ; Cohort Studies ; Disease Progression ; Female ; Genetic Testing ; Humans ; Lupus Nephritis/classification ; Lupus Nephritis/mortality ; Male ; Multivariate Analysis ; Nephrology/standards ; Risk Factors ; Societies, Medical ; Survival Analysis ; Young Adult
Czasopismo naukowe
Tytuł :
Clinicopathologic characteristics and outcomes of lupus nephritis with positive antineutrophil cytoplasmic antibody.
Autorzy :
Wang S; Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Shang J; Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Xiao J; Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Zhao Z; Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Pokaż więcej
Źródło :
Renal failure [Ren Fail] 2020 Nov; Vol. 42 (1), pp. 244-254.
Typ publikacji :
Journal Article
MeSH Terms :
Antibodies, Antineutrophil Cytoplasmic/*blood
Lupus Nephritis/*physiopathology
Adolescent ; Adult ; Female ; Glomerular Filtration Rate ; Humans ; Lung Diseases, Fungal/complications ; Lupus Nephritis/complications ; Lupus Nephritis/mortality ; Male ; Middle Aged ; Multivariate Analysis ; Retrospective Studies ; Survival Analysis ; Young Adult
Czasopismo naukowe
Tytuł :
Worse Renal Presentation and Prognosis in Initial-Onset Lupus Nephritis than Early-Onset Lupus Nephritis.
Autorzy :
Kwon OC; Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
Park JH; Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
Lee SW; Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
Song JJ; Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
Park YB; Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
Park MC; Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea. .
Pokaż więcej
Źródło :
Yonsei medical journal [Yonsei Med J] 2020 Nov; Vol. 61 (11), pp. 951-957.
Typ publikacji :
Journal Article
MeSH Terms :
Kidney/*physiopathology
Kidney Failure, Chronic/*etiology
Lupus Erythematosus, Systemic/*pathology
Lupus Nephritis/*pathology
Adult ; Biopsy ; Disease Progression ; Female ; Humans ; Lupus Erythematosus, Systemic/therapy ; Lupus Nephritis/complications ; Lupus Nephritis/therapy ; Male ; Middle Aged ; Prognosis ; Retrospective Studies ; Severity of Illness Index ; Time Factors ; Young Adult
Czasopismo naukowe
Tytuł :
Outcomes of membranous and proliferative lupus nephritis - analysis of a single-centre cohort with more than 30 years of follow-up.
Autorzy :
Farinha F; Centre for Rheumatology, University College London.
Pepper RJ; Centre for Nephrology, University College London - Royal Free Campus, London, UK.
Oliveira DG; Internal Medicine Department, Centro Hospitalar e Universitário do Porto, Porto, Portugal.
McDonnell T; Centre for Rheumatology, University College London.
Isenberg DA; Centre for Rheumatology, University College London.
Rahman A; Centre for Rheumatology, University College London.
Pokaż więcej
Źródło :
Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2020 Nov 01; Vol. 59 (11), pp. 3314-3323.
Typ publikacji :
Comparative Study; Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Lupus Nephritis/*mortality
Adult ; Antibodies/blood ; Biomarkers/blood ; Complement C3/analysis ; DNA/immunology ; Disease Progression ; Female ; Follow-Up Studies ; Glomerular Filtration Rate ; Humans ; Kaplan-Meier Estimate ; Kidney/physiology ; Lupus Nephritis/blood ; Lupus Nephritis/classification ; Lupus Nephritis/ethnology ; Male ; Regression Analysis ; Retrospective Studies ; Time Factors ; Tissue Survival
Czasopismo naukowe
Tytuł :
Per-protocol repeat kidney biopsy portends relapse and long-term outcome in incident cases of proliferative lupus nephritis.
Autorzy :
Parodis I; Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet and Rheumatology, Karolinska University Hospital, Stockholm, Sweden.
Adamichou C; Rheumatology Department, Cliniques Universitaires Saint-Luc and Pôle de Pathologies Rhumatismales Inflammatoires et Systémiques, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain.
Aydin S; Pathology Department, Cliniques Universitaires Saint-Luc.
Gomez A; Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet and Rheumatology, Karolinska University Hospital, Stockholm, Sweden.
Demoulin N; Division of Nephrology, Cliniques Universitaires Saint-Luc and Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Brussels, Belgium.
Weinmann-Menke J; Department of Nephrology, Rheumatology and Clinical Immunology, University Medical Centre of the Johannes Gutenberg-University Mainz, Mainz, Germany.
Houssiau FA; Rheumatology Department, Cliniques Universitaires Saint-Luc and Pôle de Pathologies Rhumatismales Inflammatoires et Systémiques, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain.
Tamirou F; Rheumatology Department, Cliniques Universitaires Saint-Luc and Pôle de Pathologies Rhumatismales Inflammatoires et Systémiques, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain.
Pokaż więcej
Źródło :
Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2020 Nov 01; Vol. 59 (11), pp. 3424-3434.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Kidney/*pathology
Lupus Nephritis/*pathology
Adult ; Biopsy ; Creatinine/urine ; Cyclophosphamide/therapeutic use ; Disease Progression ; Female ; Glucocorticoids/therapeutic use ; Humans ; Immunologic Factors/therapeutic use ; Immunosuppressive Agents/therapeutic use ; Kidney Tubules/pathology ; Lupus Nephritis/drug therapy ; Lupus Nephritis/urine ; Male ; Methylprednisolone/therapeutic use ; Mycophenolic Acid/therapeutic use ; Prognosis ; Proportional Hazards Models ; Proteinuria/urine ; Pulse Therapy, Drug ; Recurrence ; Retrospective Studies ; Rituximab/therapeutic use ; Young Adult
Czasopismo naukowe
Tytuł :
The utility of urinary biomarker panel in predicting renal pathology and treatment response in Chinese lupus nephritis patients.
Autorzy :
Liu L; Department of Emergency Medicine, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Wang R; Department of Rheumatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Ding H; Department of Rheumatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Tian L; Department of Emergency Medicine, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Gao T; Department of Emergency Medicine, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Bao C; Department of Rheumatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2020 Oct 27; Vol. 15 (10), pp. e0240942. Date of Electronic Publication: 2020 Oct 27 (Print Publication: 2020).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Biomarkers/*urine
Kidney/*pathology
Lupus Nephritis/*diagnosis
Lupus Nephritis/*drug therapy
Adult ; China ; Female ; Gene Expression Regulation ; Humans ; Lupus Nephritis/pathology ; Lupus Nephritis/urine ; Male ; Middle Aged ; Proteomics/methods ; Retrospective Studies ; Severity of Illness Index ; Young Adult
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies